Does ICATIBANT Cause Product dose omission issue? 421 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 421 reports of Product dose omission issue have been filed in association with ICATIBANT (Icatibant). This represents 7.9% of all adverse event reports for ICATIBANT.
421
Reports of Product dose omission issue with ICATIBANT
7.9%
of all ICATIBANT reports
8
Deaths
238
Hospitalizations
How Dangerous Is Product dose omission issue From ICATIBANT?
Of the 421 reports, 8 (1.9%) resulted in death, 238 (56.5%) required hospitalization, and 22 (5.2%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ICATIBANT. However, 421 reports have been filed with the FAERS database.
What Other Side Effects Does ICATIBANT Cause?
Hereditary angioedema (2,221)
Drug ineffective (506)
Weight decreased (386)
Weight increased (367)
Product use issue (332)
Injection site pain (331)
Inappropriate schedule of product administration (305)
Headache (294)
Malaise (262)
Covid-19 (260)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which ICATIBANT Alternatives Have Lower Product dose omission issue Risk?
ICATIBANT vs ICHTHAMMOL\ZINC
ICATIBANT vs ICLUSIG
ICATIBANT vs ICODEXTRIN
ICATIBANT vs ICOSAPENT
ICATIBANT vs ICOSAPENT ETHYL